Accuracy and Glycemic Efficacy of Continuous Glucose Monitors in Critically Ill COVID-19 Patients: A Retrospective Study

BACKGROUND: Continuous glucose monitoring (CGM) is approved for insulin dosing decisions in the ambulatory setting, but not currently for inpatients. CGM has the capacity to reduce patient-provider contact in inpatients with coronavirus disease 2019 (COVID-19), thus potentially reducing in hospital...

Descripción completa

Detalles Bibliográficos
Autores principales: Boeder, Schafer, Kobayashi, Emily, Ramesh, Gautam, Serences, Brittany, Kulasa, Kristen, Majithia, Amit R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Special Section: Diabetes Technology in the Hospital
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10159791/
https://www.ncbi.nlm.nih.gov/pubmed/35876258
http://dx.doi.org/10.1177/19322968221113865

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10159791/
https://www.ncbi.nlm.nih.gov/pubmed/35876258
http://dx.doi.org/10.1177/19322968221113865

Ejemplares similares